Polymer Drug Delivery Prostheses
CorMatrix Cardiovascular Receives European Community and U.S. Patent Claim Allowances for Polymer Drug Delivery Prostheses
The European and U.S. Patent allowances will further enhance CorMatrix's growing synthetic polymer and ECM (Extracellular Matrix) delivery platforms, which, in addition to PGS, includes poly(urethane urea), polylactide (PLA), poly(e-caprolactone) (PCL) and polyglycolide (PLGA) compositions and structures.